- Treatment results of the regimen: actively increase the radiation dose to the desired volume of radiation therapy, reduce radiation dose to organs at risk, complete 6 cycles of chemotherapy and radiotherapy at the same time is 77, 9%, from 5 cycles is 88.2%, the rate of treatment response is 100%, of which 97.1% respond completely; estimated 3 years of disease-free and overall survival outcomes were 80.7% and 84.1%, factors related to survival included treatment interruption (prolongation of radiotherapy), primary tumor volume, adherence to chemotherapy and radiotherapy, and post-treatment status.